HitFastDiscovery®, property of OriBase Pharma, is a platform built around two complementary technologies. The first one is a technology based on 3 unique software applications in chemoinformatics and the second one is a technology based on innovative chemical synthesis processes protected by industrial secret:
- MedChem Decision is a rational design tool capable of generating biologically active, patentable and synthetically feasible molecules.
- SARA is a software tool able to optimize the process of analysis and interpretation of data, and to generate predictive and robust interpretive models allowing consistent decision process.
- EZ DESIGN is a software tool that can generate and evaluate molecule libraries to retain only those that present the best ADME-Tox profile.
- ChemBase is a virtual database of innovative chemical compounds allowing chemical synthesis of new bioactive and patentable molecules.
HitFastDiscovery® Platform Advantages
- Proven and Unique platform - 5 years of development
- Accelerating & improving drug discovery process - 3 years instead of 6
- A fully integrated and iterative process to identify potent & patentable molecules.
- Accurate de novo design
- Able to design molecules synthetically feasible
- >80% of designed and profiled molecules in silico are synthetically feasible
- Provides chemical synthesis routes for each newly created molecule
- Limited number of cycles and molecules ( 2 to 3 cycles)
- Multiple bioactivity prediction